|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
INDIANA
|
|
35-2145715
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
120 MONUMENT CIRCLE
INDIANAPOLIS, INDIANA
(Address of principal executive offices)
|
|
46204-4903
(Zip Code)
|
Large accelerated filer
|
x
|
|
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
¨
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
¨
|
Emerging growth company
|
¨
|
|
|
|
|
Title of Each Class
|
|
Outstanding at April 12, 2018
|
Common Stock, $0.01 par value
|
|
255,199,261 shares
|
|
|
|
|
|
Page
|
PART I. FINANCIAL INFORMATION
|
|
|
|
|
|
ITEM 1.
|
|
|
|
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
ITEM 2.
|
||
ITEM 3.
|
||
ITEM 4.
|
||
PART II. OTHER INFORMATION
|
|
|
ITEM 1.
|
||
ITEM 1A.
|
||
ITEM 2.
|
||
ITEM 3.
|
||
ITEM 4.
|
||
ITEM 5.
|
||
ITEM 6.
|
||
ITEM 1.
|
FINANCIAL STATEMENTS
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
(In millions, except share data)
|
(Unaudited)
|
|
|
||||
Assets
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
4,630.6
|
|
|
$
|
3,608.9
|
|
Fixed maturity securities, current (amortized cost of $17,070.2 and $17,054.5)
|
17,091.5
|
|
|
17,377.3
|
|
||
Equity securities, current
|
2,341.9
|
|
|
3,599.2
|
|
||
Other invested assets, current
|
24.3
|
|
|
17.2
|
|
||
Accrued investment income
|
160.2
|
|
|
162.5
|
|
||
Premium and self-funded receivables
|
6,255.9
|
|
|
6,184.9
|
|
||
Other receivables
|
2,305.2
|
|
|
2,266.5
|
|
||
Income taxes receivable
|
—
|
|
|
341.9
|
|
||
Securities lending collateral
|
612.2
|
|
|
455.1
|
|
||
Other current assets
|
3,552.3
|
|
|
2,249.3
|
|
||
Total current assets
|
36,974.1
|
|
|
36,262.8
|
|
||
Long-term investments:
|
|
|
|
||||
Fixed maturity securities (amortized cost of $504.1 and $556.0)
|
501.5
|
|
|
560.8
|
|
||
Equity securities
|
32.9
|
|
|
32.8
|
|
||
Other invested assets
|
3,460.8
|
|
|
3,343.8
|
|
||
Property and equipment, net
|
2,237.6
|
|
|
2,174.9
|
|
||
Goodwill
|
20,185.5
|
|
|
19,231.2
|
|
||
Other intangible assets
|
9,076.0
|
|
|
8,368.4
|
|
||
Other noncurrent assets
|
832.0
|
|
|
565.3
|
|
||
Total assets
|
$
|
73,300.4
|
|
|
$
|
70,540.0
|
|
|
|
|
|
||||
Liabilities and shareholders’ equity
|
|
|
|
||||
Liabilities
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Policy liabilities:
|
|
|
|
||||
Medical claims payable
|
$
|
7,640.3
|
|
|
$
|
7,991.5
|
|
Reserves for future policy benefits
|
71.5
|
|
|
69.9
|
|
||
Other policyholder liabilities
|
2,918.8
|
|
|
2,950.3
|
|
||
Total policy liabilities
|
10,630.6
|
|
|
11,011.7
|
|
||
Unearned income
|
2,115.9
|
|
|
860.3
|
|
||
Accounts payable and accrued expenses
|
5,816.7
|
|
|
5,024.4
|
|
||
Income taxes payable
|
194.9
|
|
|
—
|
|
||
Security trades pending payable
|
134.7
|
|
|
112.6
|
|
||
Securities lending payable
|
611.8
|
|
|
454.4
|
|
||
Short-term borrowings
|
1,125.0
|
|
|
1,275.0
|
|
||
Current portion of long-term debt
|
650.8
|
|
|
1,274.6
|
|
||
Other current liabilities
|
3,475.5
|
|
|
3,343.0
|
|
||
Total current liabilities
|
24,755.9
|
|
|
23,356.0
|
|
||
Long-term debt, less current portion
|
18,110.1
|
|
|
17,382.2
|
|
||
Reserves for future policy benefits, noncurrent
|
666.8
|
|
|
647.3
|
|
||
Deferred tax liabilities, net
|
1,812.9
|
|
|
1,726.5
|
|
||
Other noncurrent liabilities
|
942.3
|
|
|
925.1
|
|
||
Total liabilities
|
46,288.0
|
|
|
44,037.1
|
|
||
|
|
|
|
||||
Commitment and contingencies – Note 11
|
|
|
|
|
|
||
Shareholders’ equity
|
|
|
|
||||
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none
|
—
|
|
|
—
|
|
||
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding –
255,544,728 and 256,084,913
|
2.6
|
|
|
2.6
|
|
||
Additional paid-in capital
|
8,489.3
|
|
|
8,547.4
|
|
||
Retained earnings
|
19,241.1
|
|
|
18,054.4
|
|
||
Accumulated other comprehensive loss
|
(720.6
|
)
|
|
(101.5
|
)
|
||
Total shareholders’ equity
|
27,012.4
|
|
|
26,502.9
|
|
||
Total liabilities and shareholders’ equity
|
$
|
73,300.4
|
|
|
$
|
70,540.0
|
|
|
Three Months Ended
March 31 |
||||||
(In millions, except per share data)
|
2018
|
|
2017
|
||||
Revenues
|
|
|
|
||||
Premiums
|
$
|
20,902.8
|
|
|
$
|
20,951.3
|
|
Administrative fees
|
1,408.8
|
|
|
1,363.2
|
|
||
Other revenue
|
30.7
|
|
|
5.0
|
|
||
Total operating revenue
|
22,342.3
|
|
|
22,319.5
|
|
||
Net investment income
|
229.2
|
|
|
207.2
|
|
||
Net realized (losses) gains on financial instruments
|
(26.1
|
)
|
|
7.3
|
|
||
Other-than-temporary impairment losses on investments:
|
|
|
|
||||
Total other-than-temporary impairment losses on investments
|
(7.9
|
)
|
|
(9.6
|
)
|
||
Portion of other-than-temporary impairment losses recognized in other comprehensive income
|
—
|
|
|
1.5
|
|
||
Other-than-temporary impairment losses recognized in income
|
(7.9
|
)
|
|
(8.1
|
)
|
||
Total revenues
|
22,537.5
|
|
|
22,525.9
|
|
||
Expenses
|
|
|
|
||||
Benefit expense
|
17,045.9
|
|
|
17,542.8
|
|
||
Selling, general and administrative and expense:
|
|
|
|
||||
Selling expense
|
318.2
|
|
|
348.6
|
|
||
General and administrative expense
|
3,110.3
|
|
|
2,842.7
|
|
||
Total selling, general and administrative expense
|
3,428.5
|
|
|
3,191.3
|
|
||
Interest expense
|
184.2
|
|
|
235.0
|
|
||
Amortization of other intangible assets
|
79.5
|
|
|
41.8
|
|
||
Loss on extinguishment of debt
|
19.1
|
|
|
—
|
|
||
Total expenses
|
20,757.2
|
|
|
21,010.9
|
|
||
Income before income tax expense
|
1,780.3
|
|
|
1,515.0
|
|
||
Income tax expense
|
467.8
|
|
|
505.1
|
|
||
Net income
|
$
|
1,312.5
|
|
|
$
|
1,009.9
|
|
Net income per share
|
|
|
|
||||
Basic
|
$
|
5.13
|
|
|
$
|
3.82
|
|
Diluted
|
$
|
4.99
|
|
|
$
|
3.73
|
|
Dividends per share
|
$
|
0.75
|
|
|
$
|
0.65
|
|
|
Three Months Ended
March 31 |
||||||
(In millions)
|
2018
|
|
2017
|
||||
Net income
|
$
|
1,312.5
|
|
|
$
|
1,009.9
|
|
Other comprehensive (loss) income, net of tax:
|
|
|
|
||||
Change in net unrealized gains/losses on investments
|
(244.7
|
)
|
|
80.2
|
|
||
Change in non-credit component of other-than-temporary impairment losses on investments
|
0.2
|
|
|
3.6
|
|
||
Change in net unrealized losses on cash flow hedges
|
28.8
|
|
|
17.0
|
|
||
Change in net periodic pension and postretirement costs
|
7.7
|
|
|
3.9
|
|
||
Foreign currency translation adjustments
|
0.4
|
|
|
1.4
|
|
||
Other comprehensive (loss) income
|
(207.6
|
)
|
|
106.1
|
|
||
Total comprehensive income
|
$
|
1,104.9
|
|
|
$
|
1,116.0
|
|
|
Three Months Ended
March 31 |
||||||
(In millions)
|
2018
|
|
2017
|
||||
Operating activities
|
|
|
|
||||
Net income
|
$
|
1,312.5
|
|
|
$
|
1,009.9
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Net realized losses (gains) on financial instruments
|
26.1
|
|
|
(7.3
|
)
|
||
Other-than-temporary impairment losses recognized in income
|
7.9
|
|
|
8.1
|
|
||
Loss on extinguishment of debt
|
19.1
|
|
|
—
|
|
||
Loss on disposal of assets
|
—
|
|
|
0.7
|
|
||
Deferred income taxes
|
(51.5
|
)
|
|
(157.2
|
)
|
||
Amortization, net of accretion
|
239.7
|
|
|
193.4
|
|
||
Depreciation expense
|
30.0
|
|
|
27.3
|
|
||
Share-based compensation
|
42.2
|
|
|
42.7
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Receivables, net
|
36.7
|
|
|
276.3
|
|
||
Other invested assets
|
(6.8
|
)
|
|
(14.8
|
)
|
||
Other assets
|
(391.8
|
)
|
|
(205.2
|
)
|
||
Policy liabilities
|
(560.8
|
)
|
|
130.1
|
|
||
Unearned income
|
1,182.2
|
|
|
954.2
|
|
||
Accounts payable and accrued expenses
|
(300.4
|
)
|
|
(223.8
|
)
|
||
Other liabilities
|
147.4
|
|
|
40.3
|
|
||
Income taxes
|
536.8
|
|
|
659.7
|
|
||
Other, net
|
(54.4
|
)
|
|
(46.2
|
)
|
||
Net cash provided by operating activities
|
2,214.9
|
|
|
2,688.2
|
|
||
Investing activities
|
|
|
|
||||
Purchases of fixed maturity securities
|
(2,235.4
|
)
|
|
(4,030.1
|
)
|
||
Proceeds from fixed maturity securities:
|
|
|
|
||||
Sales
|
1,864.4
|
|
|
2,851.8
|
|
||
Maturities, calls and redemptions
|
362.9
|
|
|
522.7
|
|
||
Purchases of equity securities
|
(566.3
|
)
|
|
(367.0
|
)
|
||
Proceeds from sales of equity securities
|
1,775.8
|
|
|
63.0
|
|
||
Purchases of other invested assets
|
(72.3
|
)
|
|
(73.7
|
)
|
||
Proceeds from sales of other invested assets
|
23.1
|
|
|
76.5
|
|
||
Change in collateral and settlements of non-hedging derivatives
|
—
|
|
|
0.4
|
|
||
Changes in securities lending collateral
|
(157.4
|
)
|
|
(154.5
|
)
|
||
Purchases of subsidiaries, net of cash acquired
|
(1,346.1
|
)
|
|
—
|
|
||
Purchases of property and equipment
|
(218.2
|
)
|
|
(127.9
|
)
|
||
Other, net
|
3.6
|
|
|
11.8
|
|
||
Net cash used in investing activities
|
(565.9
|
)
|
|
(1,227.0
|
)
|
||
Financing activities
|
|
|
|
||||
Net (repayments of) proceeds from commercial paper borrowings
|
(108.0
|
)
|
|
1,719.1
|
|
||
Proceeds from long-term borrowings
|
836.0
|
|
|
—
|
|
||
Repayments of long-term borrowings
|
(662.7
|
)
|
|
(401.1
|
)
|
||
Proceeds from short-term borrowings
|
1,505.0
|
|
|
1,170.0
|
|
||
Repayments of short-term borrowings
|
(1,655.0
|
)
|
|
(1,070.0
|
)
|
||
Changes in securities lending payable
|
157.4
|
|
|
154.5
|
|
||
Changes in bank overdrafts
|
(124.4
|
)
|
|
(168.9
|
)
|
||
Proceeds from sale of put options
|
0.3
|
|
|
—
|
|
||
Repurchase and retirement of common stock
|
(394.7
|
)
|
|
(50.7
|
)
|
||
Change in collateral and settlements of debt-related derivatives
|
24.1
|
|
|
(8.0
|
)
|
||
Cash dividends
|
(191.9
|
)
|
|
(172.2
|
)
|
||
Proceeds from issuance of common stock under employee stock plans
|
59.4
|
|
|
103.5
|
|
||
Taxes paid through withholding of common stock under employee stock plans
|
(73.2
|
)
|
|
(41.9
|
)
|
||
Net cash (used in) provided by financing activities
|
(627.7
|
)
|
|
1,234.3
|
|
||
Effect of foreign exchange rates on cash and cash equivalents
|
0.4
|
|
|
1.6
|
|
||
Change in cash and cash equivalents
|
1,021.7
|
|
|
2,697.1
|
|
||
Cash and cash equivalents at beginning of period
|
3,608.9
|
|
|
4,075.3
|
|
||
Cash and cash equivalents at end of period
|
$
|
4,630.6
|
|
|
$
|
6,772.4
|
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Total
Shareholders’
Equity
|
|||||||||||||
(In millions)
|
Number of
Shares
|
|
Par
Value
|
|
||||||||||||||||||
December 31, 2017 (audited)
|
256.1
|
|
|
$
|
2.6
|
|
|
$
|
8,547.4
|
|
|
$
|
18,054.4
|
|
|
$
|
(101.5
|
)
|
|
$
|
26,502.9
|
|
Adoption of Accounting Standards Update No 2016-01 (Note 2)
|
—
|
|
|
—
|
|
|
—
|
|
|
320.2
|
|
|
(320.2
|
)
|
|
—
|
|
|||||
January 1, 2018
|
256.1
|
|
|
2.6
|
|
|
8,547.4
|
|
|
18,374.6
|
|
|
(421.7
|
)
|
|
26,502.9
|
|
|||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
1,312.5
|
|
|
—
|
|
|
1,312.5
|
|
|||||
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(207.6
|
)
|
|
(207.6
|
)
|
|||||
Premiums for and settlement of equity options
|
—
|
|
|
—
|
|
|
0.3
|
|
|
—
|
|
|
—
|
|
|
0.3
|
|
|||||
Repurchase and retirement of common stock
|
(1.7
|
)
|
|
—
|
|
|
(56.5
|
)
|
|
(338.2
|
)
|
|
—
|
|
|
(394.7
|
)
|
|||||
Dividends and dividend equivalents
|
—
|
|
|
—
|
|
|
—
|
|
|
(199.1
|
)
|
|
—
|
|
|
(199.1
|
)
|
|||||
Issuance of common stock under employee stock plans, net of related tax benefits
|
1.1
|
|
|
—
|
|
|
28.4
|
|
|
—
|
|
|
—
|
|
|
28.4
|
|
|||||
Convertible debenture repurchases and conversions
|
—
|
|
|
—
|
|
|
(30.3
|
)
|
|
—
|
|
|
—
|
|
|
(30.3
|
)
|
|||||
Adoption of Accounting Standards Update No 2018-02 (Note 2)
|
—
|
|
|
—
|
|
|
—
|
|
|
91.3
|
|
|
(91.3
|
)
|
|
—
|
|
|||||
March 31, 2018
|
255.5
|
|
|
$
|
2.6
|
|
|
$
|
8,489.3
|
|
|
$
|
19,241.1
|
|
|
$
|
(720.6
|
)
|
|
$
|
27,012.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
January 1, 2017
|
263.7
|
|
|
$
|
2.6
|
|
|
$
|
8,805.1
|
|
|
$
|
16,560.6
|
|
|
$
|
(267.9
|
)
|
|
$
|
25,100.4
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
1,009.9
|
|
|
—
|
|
|
1,009.9
|
|
|||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
106.1
|
|
|
106.1
|
|
|||||
Repurchase and retirement of common stock
|
(0.3
|
)
|
|
—
|
|
|
(10.5
|
)
|
|
(40.2
|
)
|
|
—
|
|
|
(50.7
|
)
|
|||||
Dividends and dividend equivalents
|
—
|
|
|
—
|
|
|
—
|
|
|
(172.6
|
)
|
|
—
|
|
|
(172.6
|
)
|
|||||
Issuance of common stock under employee stock plans, net of related tax benefits
|
1.7
|
|
|
—
|
|
|
99.9
|
|
|
—
|
|
|
—
|
|
|
99.9
|
|
|||||
Convertible debenture repurchases and conversions
|
—
|
|
|
—
|
|
|
(1.1
|
)
|
|
—
|
|
|
—
|
|
|
(1.1
|
)
|
|||||
March 31, 2017
|
265.1
|
|
|
$
|
2.6
|
|
|
$
|
8,893.4
|
|
|
$
|
17,357.7
|
|
|
$
|
(161.8
|
)
|
|
$
|
26,091.9
|
|
1.
|
Organization
|
2.
|
Basis of Presentation and Significant Accounting Policies
|
3.
|
Business Acquisitions
|
4.
|
Investments
|
|
|
|
|
|
|
|
|
|
Non-Credit
Component of
Other-Than-
Temporary Impairments Recognized in Accumulated
Other
Comprehensive
Loss
|
||||||||||||||
|
Cost or
Amortized Cost |
|
Gross
Unrealized Gains |
|
Gross Unrealized Losses
|
|
Estimated
Fair Value |
|
|||||||||||||||
|
|
|
Less than
12 Months
|
|
12 Months
or Greater
|
|
|
||||||||||||||||
March 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
United States Government securities
|
$
|
589.0
|
|
|
$
|
2.3
|
|
|
$
|
(6.9
|
)
|
|
$
|
(0.9
|
)
|
|
$
|
583.5
|
|
|
$
|
—
|
|
Government sponsored securities
|
105.6
|
|
|
0.2
|
|
|
(0.5
|
)
|
|
(0.5
|
)
|
|
104.8
|
|
|
—
|
|
||||||
States, municipalities and political subdivisions, tax-exempt
|
5,312.3
|
|
|
102.1
|
|
|
(23.3
|
)
|
|
(11.5
|
)
|
|
5,379.6
|
|
|
—
|
|
||||||
Corporate securities
|
7,651.6
|
|
|
85.9
|
|
|
(97.0
|
)
|
|
(18.2
|
)
|
|
7,622.3
|
|
|
—
|
|
||||||
Residential mortgage-backed securities
|
2,786.1
|
|
|
32.2
|
|
|
(32.7
|
)
|
|
(20.0
|
)
|
|
2,765.6
|
|
|
—
|
|
||||||
Commercial mortgage-backed securities
|
78.0
|
|
|
0.3
|
|
|
(0.4
|
)
|
|
(2.2
|
)
|
|
75.7
|
|
|
—
|
|
||||||
Other securities
|
1,051.7
|
|
|
16.1
|
|
|
(5.3
|
)
|
|
(1.0
|
)
|
|
1,061.5
|
|
|
—
|
|
||||||
Total fixed maturity securities
|
$
|
17,574.3
|
|
|
$
|
239.1
|
|
|
$
|
(166.1
|
)
|
|
$
|
(54.3
|
)
|
|
$
|
17,593.0
|
|
|
$
|
—
|
|
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
United States Government securities
|
$
|
649.0
|
|
|
$
|
2.2
|
|
|
$
|
(5.0
|
)
|
|
$
|
(0.7
|
)
|
|
$
|
645.5
|
|
|
$
|
—
|
|
Government sponsored securities
|
90.3
|
|
|
0.3
|
|
|
(0.1
|
)
|
|
(0.4
|
)
|
|
90.1
|
|
|
—
|
|
||||||
States, municipalities and political subdivisions, tax-exempt
|
5,854.6
|
|
|
192.6
|
|
|
(5.0
|
)
|
|
(7.3
|
)
|
|
6,034.9
|
|
|
—
|
|
||||||
Corporate securities
|
7,362.8
|
|
|
165.8
|
|
|
(30.2
|
)
|
|
(12.6
|
)
|
|
7,485.8
|
|
|
(0.3
|
)
|
||||||
Residential mortgage-backed securities
|
2,520.0
|
|
|
38.5
|
|
|
(8.0
|
)
|
|
(11.6
|
)
|
|
2,538.9
|
|
|
—
|
|
||||||
Commercial mortgage-backed securities
|
80.1
|
|
|
0.7
|
|
|
(0.1
|
)
|
|
(2.0
|
)
|
|
78.7
|
|
|
—
|
|
||||||
Other securities
|
1,053.7
|
|
|
14.4
|
|
|
(2.4
|
)
|
|
(1.5
|
)
|
|
1,064.2
|
|
|
—
|
|
||||||
Total fixed maturity securities
|
$
|
17,610.5
|
|
|
$
|
414.5
|
|
|
$
|
(50.8
|
)
|
|
$
|
(36.1
|
)
|
|
$
|
17,938.1
|
|
|
$
|
(0.3
|
)
|
|
Less than 12 Months
|
|
12 Months or Greater
|
||||||||||||||||||
(Securities are whole amounts)
|
Number of
Securities
|
|
Estimated
Fair Value
|
|
Gross
Unrealized
Loss
|
|
Number of
Securities
|
|
Estimated
Fair Value
|
|
Gross
Unrealized
Loss
|
||||||||||
March 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
United States Government securities
|
36
|
|
|
$
|
291.9
|
|
|
$
|
(6.9
|
)
|
|
13
|
|
|
$
|
82.8
|
|
|
$
|
(0.9
|
)
|
Government sponsored securities
|
19
|
|
|
28.4
|
|
|
(0.5
|
)
|
|
16
|
|
|
14.0
|
|
|
(0.5
|
)
|
||||
States, municipalities and political subdivisions, tax-exempt
|
848
|
|
|
1,638.9
|
|
|
(23.3
|
)
|
|
167
|
|
|
277.5
|
|
|
(11.5
|
)
|
||||
Corporate securities
|
2,023
|
|
|
4,225.6
|
|
|
(97.0
|
)
|
|
262
|
|
|
304.5
|
|
|
(18.2
|
)
|
||||
Residential mortgage-backed securities
|
712
|
|
|
1,572.8
|
|
|
(32.7
|
)
|
|
287
|
|
|
470.8
|
|
|
(20.0
|
)
|
||||
Commercial mortgage-backed securities
|
15
|
|
|
26.2
|
|
|
(0.4
|
)
|
|
12
|
|
|
25.5
|
|
|
(2.2
|
)
|
||||
Other securities
|
172
|
|
|
528.7
|
|
|
(5.3
|
)
|
|
17
|
|
|
23.4
|
|
|
(1.0
|
)
|
||||
Total fixed maturity securities
|
3,825
|
|
|
$
|
8,312.5
|
|
|
$
|
(166.1
|
)
|
|
774
|
|
|
$
|
1,198.5
|
|
|
$
|
(54.3
|
)
|
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
United States Government securities
|
36
|
|
|
$
|
450.4
|
|
|
$
|
(5.0
|
)
|
|
11
|
|
|
$
|
56.1
|
|
|
$
|
(0.7
|
)
|
Government sponsored securities
|
12
|
|
|
16.3
|
|
|
(0.1
|
)
|
|
16
|
|
|
14.8
|
|
|
(0.4
|
)
|
||||
States, municipalities and political subdivisions, tax-exempt
|
414
|
|
|
641.4
|
|
|
(5.0
|
)
|
|
189
|
|
|
355.5
|
|
|
(7.3
|
)
|
||||
Corporate securities
|
1,081
|
|
|
2,200.1
|
|
|
(30.2
|
)
|
|
279
|
|
|
329.7
|
|
|
(12.6
|
)
|
||||
Residential mortgage-backed securities
|
445
|
|
|
1,050.3
|
|
|
(8.0
|
)
|
|
287
|
|
|
478.0
|
|
|
(11.6
|
)
|
||||
Commercial mortgage-backed securities
|
7
|
|
|
13.7
|
|
|
(0.1
|
)
|
|
12
|
|
|
27.2
|
|
|
(2.0
|
)
|
||||
Other securities
|
132
|
|
|
406.1
|
|
|
(2.4
|
)
|
|
20
|
|
|
35.8
|
|
|
(1.5
|
)
|
||||
Total fixed maturity securities
|
2,127
|
|
|
$
|
4,778.3
|
|
|
$
|
(50.8
|
)
|
|
814
|
|
|
$
|
1,297.1
|
|
|
$
|
(36.1
|
)
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
||||
Due in one year or less
|
$
|
526.5
|
|
|
$
|
526.3
|
|
Due after one year through five years
|
4,969.7
|
|
|
4,973.8
|
|
||
Due after five years through ten years
|
5,322.5
|
|
|
5,313.4
|
|
||
Due after ten years
|
3,891.5
|
|
|
3,938.2
|
|
||
Mortgage-backed securities
|
2,864.1
|
|
|
2,841.3
|
|
||
Total fixed maturity securities
|
$
|
17,574.3
|
|
|
$
|
17,593.0
|
|
|
Three Months Ended
March 31 |
||||||
|
2018
|
|
2017
|
||||
Proceeds
|
$
|
2,227.3
|
|
|
$
|
3,374.5
|
|
Gross realized gains
|
29.7
|
|
|
45.5
|
|
||
Gross realized losses
|
(36.4
|
)
|
|
(23.7
|
)
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
Equity securities:
|
|
|
|
||||
Exchange traded funds
|
$
|
510.6
|
|
|
$
|
1,300.3
|
|
Fixed maturity mutual funds
|
656.4
|
|
|
790.6
|
|
||
Common equity securities
|
904.4
|
|
|
1,253.7
|
|
||
Private equity securities
|
303.4
|
|
|
287.4
|
|
||
Total
|
$
|
2,374.8
|
|
|
$
|
3,632.0
|
|
|
Three Months Ended March 31, 2018
|
||
Gross realized gains recognized on securities sold during the period
|
$
|
172.9
|
|
Gross unrealized losses recognized on securities still held at March 31, 2018
|
(215.9
|
)
|
|
Net realized losses recognized
|
$
|
(43.0
|
)
|
|
Overnight and Continuous
|
||
Securities lending transactions
|
|
||
United States Government securities
|
$
|
20.8
|
|
Corporate securities
|
447.2
|
|
|
Equity securities
|
143.8
|
|
|
Total
|
$
|
611.8
|
|
5.
|
Derivative Financial Instruments
|
|
Contractual/
Notional
Amount
|
|
Balance Sheet Location
|
|
Estimated Fair Value
|
||||||||
|
Asset
|
|
(Liability)
|
||||||||||
March 31, 2018
|
|
|
|
|
|
|
|
||||||
Hedging instruments
|
|
|
|
|
|
|
|
||||||
Interest rate swaps - fixed to floating
|
$
|
1,000.0
|
|
|
Other assets/other liabilities
|
|
$
|
1.1
|
|
|
$
|
(11.7
|
)
|
Non-hedging instruments
|
|
|
|
|
|
|
|
||||||
Interest rate swaps
|
253.3
|
|
|
Equity securities
|
|
1.4
|
|
|
(7.8
|
)
|
|||
Futures
|
264.2
|
|
|
Equity securities
|
|
1.0
|
|
|
(5.1
|
)
|
|||
Subtotal non-hedging
|
517.5
|
|
|
Subtotal non-hedging
|
|
2.4
|
|
|
(12.9
|
)
|
|||
Total derivatives
|
$
|
1,517.5
|
|
|
Total derivatives
|
|
3.5
|
|
|
(24.6
|
)
|
||
|
|
|
Amounts netted
|
|
(2.9
|
)
|
|
2.9
|
|
||||
|
|
|
Net derivatives
|
|
$
|
0.6
|
|
|
$
|
(21.7
|
)
|
||
|
|
|
|
|
|
|
|
||||||
December 31, 2017
|
|
|
|
|
|
|
|
||||||
Hedging instruments
|
|
|
|
|
|
|
|
||||||
Interest rate swaps - fixed to floating
|
$
|
1,235.0
|
|
|
Other assets/other liabilities
|
|
$
|
2.0
|
|
|
$
|
(5.3
|
)
|
Interest rate swaps - forward starting pay fixed
|
425.0
|
|
|
Other assets/other liabilities
|
|
—
|
|
|
(8.9
|
)
|
|||
Subtotal hedging
|
1,660.0
|
|
|
Subtotal hedging
|
|
2.0
|
|
|
(14.2
|
)
|
|||
Non-hedging instruments
|
|
|
|
|
|
|
|
||||||
Interest rate swaps
|
171.3
|
|
|
Equity securities
|
|
1.0
|
|
|
(4.7
|
)
|
|||
Options
|
100.0
|
|
|
Other assets/other liabilities
|
|
—
|
|
|
(0.1
|
)
|
|||
Futures
|
116.8
|
|
|
Equity securities
|
|
0.1
|
|
|
(2.5
|
)
|
|||
Subtotal non-hedging
|
388.1
|
|
|
Subtotal non-hedging
|
|
1.1
|
|
|
(7.3
|
)
|
|||
Total derivatives
|
$
|
2,048.1
|
|
|
Total derivatives
|
|
3.1
|
|
|
(21.5
|
)
|
||
|
|
|
Amounts netted
|
|
(1.6
|
)
|
|
1.6
|
|
||||
|
|
|
Net derivatives
|
|
$
|
1.5
|
|
|
$
|
(19.9
|
)
|
Type of Fair Value Hedges
|
|
Year
Entered
Into
|
|
Outstanding Notional Amount
|
|
Interest Rate
Received
|
|
Expiration Date
|
|||||||
|
March 31, 2018
|
|
December 31, 2017
|
|
|||||||||||
Interest rate swap
|
|
2018
|
|
$
|
300.0
|
|
|
$
|
—
|
|
|
3.300
|
%
|
|
January 15, 2023
|
Interest rate swap
|
|
2018
|
|
90.0
|
|
|
—
|
|
|
4.350
|
|
|
August 15, 2020
|
||
Interest rate swap
|
|
2017
|
|
50.0
|
|
|
50.0
|
|
|
4.350
|
|
|
August 15, 2020
|
||
Interest rate swap
|
|
2015
|
|
200.0
|
|
|
200.0
|
|
|
4.350
|
|
|
August 15, 2020
|
||
Interest rate swap
|
|
2014
|
|
150.0
|
|
|
150.0
|
|
|
4.350
|
|
|
August 15, 2020
|
||
Interest rate swap
|
|
2013
|
|
10.0
|
|
|
10.0
|
|
|
4.350
|
|
|
August 15, 2020
|
||
Interest rate swap
|
|
2012
|
|
200.0
|
|
|
200.0
|
|
|
4.350
|
|
|
August 15, 2020
|
||
Interest rate swap
|
|
2012
|
|
—
|
|
|
625.0
|
|
|
1.875
|
|
|
January 15, 2018
|
||
Total notional amount outstanding
|
|
|
|
$
|
1,000.0
|
|
|
$
|
1,235.0
|
|
|
|
|
|
|
Balance Sheet Classification in Which Hedged Item is Included
|
|
Carrying Amount of Hedged Liability
|
|
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability
|
||||||||||||
|
March 31, 2018
|
|
December 31, 2017
|
|
March 31, 2018
|
|
December 31, 2017
|
|||||||||
Current portion of long term-debt
|
|
$
|
650.8
|
|
|
$
|
1,274.6
|
|
|
$
|
1.1
|
|
|
$
|
2.0
|
|
Long-term debt
|
|
18,110.1
|
|
|
17,382.2
|
|
|
(11.7
|
)
|
|
(5.3
|
)
|
|
|
Hedge
Income Recognized in Other Comprehensive (Loss) Income |
|
Income Statement Location of
Loss Reclassification from
Accumulated Other Comprehensive Loss
|
|
Hedge Loss
Reclassified from Accumulated Other Comprehensive Loss |
||||
Type of Cash Flow Hedge
|
|
|
|
|||||||
Three months ended March 31, 2018
|
|
|
|
|
|
|
||||
Forward starting pay fixed swaps
|
|
$
|
33.3
|
|
|
Interest expense
|
|
$
|
(3.2
|
)
|
Three months ended March 31, 2017
|
|
|
|
|
|
|
||||
Forward starting pay fixed swaps
|
|
$
|
18.3
|
|
|
Interest expense
|
|
$
|
(1.5
|
)
|
Forward starting pay fixed swaps
|
|
|
|
Net realized (losses) gains on financial instruments
|
|
$
|
(12.0
|
)
|
|
Classification and Amount of (Loss) Gain Recognized in Income on Fair Value and Cash Flow Hedging Relationships
|
||||||||||||||
|
Three Months Ended March 31, 2018
|
|
Three Months Ended March 31, 2017
|
||||||||||||
|
Net Realized (Losses) Gains on Financial Instruments
|
|
Interest Expense
|
|
Net Realized (Losses) Gains on Financial Instruments
|
|
Interest Expense
|
||||||||
Total amount of income or expense in the income statement in which the effects of fair value or cash flow hedges are recorded
|
$
|
(26.1
|
)
|
|
$
|
(184.2
|
)
|
|
$
|
7.3
|
|
|
$
|
(235.0
|
)
|
|
|
|
|
|
|
|
|
||||||||
Loss (gain) on fair value hedging relationships:
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps
|
|
|
|
|
|
|
|
||||||||
Hedged items
|
—
|
|
|
(0.4
|
)
|
|
—
|
|
|
(0.2
|
)
|
||||
Derivatives designated as hedging instruments
|
—
|
|
|
0.4
|
|
|
—
|
|
|
0.2
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Loss on cash flow hedging relationships:
|
|
|
|
|
|
|
|
||||||||
Forward starting pay fixed swaps
|
|
|
|
|
|
|
|
||||||||
Amount of loss reclassified from accumulated other comprehensive loss into net income
|
—
|
|
|
(3.2
|
)
|
|
—
|
|
|
(1.5
|
)
|
||||
Amount of loss reclassified from accumulated other comprehensive loss into net income due to ineffectiveness and missed forecasted transactions
|
—
|
|
|
—
|
|
|
(12.0
|
)
|
|
—
|
|
Type of Non-hedging Derivatives
|
|
Income Statement Location of Loss Recognized
|
|
Derivative
Gain (Loss)
Recognized
|
||
Three months ended March 31, 2018
|
|
|
|
|
||
Interest rate swaps
|
|
Net realized (losses) gains on financial instruments
|
|
$
|
(2.4
|
)
|
Options
|
|
Net realized (losses) gains on financial instruments
|
|
(0.7
|
)
|
|
Futures
|
|
Net realized (losses) gains on financial instruments
|
|
3.0
|
|
|
Total
|
|
|
|
$
|
(0.1
|
)
|
Three months ended March 31, 2017
|
|
|
|
|
||
Interest rate swaps
|
|
Net realized (losses) gains on financial instruments
|
|
$
|
0.6
|
|
Options
|
|
Net realized (losses) gains on financial instruments
|
|
(10.5
|
)
|
|
Futures
|
|
Net realized (losses) gains on financial instruments
|
|
(0.4
|
)
|
|
Total
|
|
|
|
$
|
(10.3
|
)
|
6.
|
Fair Value
|
Level Input
|
|
Input Definition
|
Level I
|
|
Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
|
Level II
|
|
Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
|
Level III
|
|
Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||
March 31, 2018
|
|
|
|
|
|
|
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
$
|
1,542.6
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,542.6
|
|
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
||||||||
United States Government securities
|
—
|
|
|
583.5
|
|
|
—
|
|
|
583.5
|
|
||||
Government sponsored securities
|
—
|
|
|
104.8
|
|
|
—
|
|
|
104.8
|
|
||||
States, municipalities and political subdivisions, tax-exempt
|
—
|
|
|
5,379.6
|
|
|
—
|
|
|
5,379.6
|
|
||||
Corporate securities
|
39.5
|
|
|
7,322.3
|
|
|
260.5
|
|
|
7,622.3
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
2,760.9
|
|
|
4.7
|
|
|
2,765.6
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
75.7
|
|
|
—
|
|
|
75.7
|
|
||||
Other securities
|
—
|
|
|
1,047.8
|
|
|
13.7
|
|
|
1,061.5
|
|
||||
Total fixed maturity securities, available-for-sale
|
39.5
|
|
|
17,274.6
|
|
|
278.9
|
|
|
17,593.0
|
|
||||
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Exchange traded funds
|
510.6
|
|
|
—
|
|
|
—
|
|
|
510.6
|
|
||||
Fixed maturity mutual funds
|
—
|
|
|
656.4
|
|
|
—
|
|
|
656.4
|
|
||||
Common equity securities
|
836.3
|
|
|
68.1
|
|
|
—
|
|
|
904.4
|
|
||||
Private equity securities
|
—
|
|
|
—
|
|
|
303.4
|
|
|
303.4
|
|
||||
Total equity securities
|
1,346.9
|
|
|
724.5
|
|
|
303.4
|
|
|
2,374.8
|
|
||||
Other invested assets, current
|
24.3
|
|
|
—
|
|
|
—
|
|
|
24.3
|
|
||||
Securities lending collateral
|
433.9
|
|
|
178.3
|
|
|
—
|
|
|
612.2
|
|
||||
Derivatives
|
—
|
|
|
3.5
|
|
|
—
|
|
|
3.5
|
|
||||
Total assets
|
$
|
3,387.2
|
|
|
$
|
18,180.9
|
|
|
$
|
582.3
|
|
|
$
|
22,150.4
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Derivatives
|
$
|
—
|
|
|
$
|
(24.6
|
)
|
|
$
|
—
|
|
|
$
|
(24.6
|
)
|
Total liabilities
|
$
|
—
|
|
|
$
|
(24.6
|
)
|
|
$
|
—
|
|
|
$
|
(24.6
|
)
|
|
|
|
|
|
|
|
|
||||||||
December 31, 2017
|
|
|
|
|
|
|
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents
|
$
|
1,956.4
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,956.4
|
|
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
||||||||
United States Government securities
|
—
|
|
|
645.5
|
|
|
—
|
|
|
645.5
|
|
||||
Government sponsored securities
|
—
|
|
|
90.1
|
|
|
—
|
|
|
90.1
|
|
||||
States, municipalities and political subdivisions, tax-exempt
|
—
|
|
|
6,034.9
|
|
|
—
|
|
|
6,034.9
|
|
||||
Corporate securities
|
24.8
|
|
|
7,231.8
|
|
|
229.2
|
|
|
7,485.8
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
2,533.9
|
|
|
5.0
|
|
|
2,538.9
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
78.7
|
|
|
—
|
|
|
78.7
|
|
||||
Other securities
|
75.2
|
|
|
973.1
|
|
|
15.9
|
|
|
1,064.2
|
|
||||
Total fixed maturity securities, available-for-sale
|
100.0
|
|
|
17,588.0
|
|
|
250.1
|
|
|
17,938.1
|
|
||||
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Exchange traded funds
|
1,300.3
|
|
|
—
|
|
|
—
|
|
|
1,300.3
|
|
||||
Fixed maturity mutual funds
|
—
|
|
|
790.6
|
|
|
—
|
|
|
790.6
|
|
||||
Common equity securities
|
1,146.6
|
|
|
107.1
|
|
|
—
|
|
|
1,253.7
|
|
||||
Private equity securities
|
—
|
|
|
—
|
|
|
287.4
|
|
|
287.4
|
|
||||
Total equity securities
|
2,446.9
|
|
|
897.7
|
|
|
287.4
|
|
|
3,632.0
|
|
||||
Other invested assets, current
|
17.2
|
|
|
—
|
|
|
—
|
|
|
17.2
|
|
||||
Securities lending collateral
|
214.1
|
|
|
241.0
|
|
|
—
|
|
|
455.1
|
|
||||
Derivatives
|
—
|
|
|
3.1
|
|
|
—
|
|
|
3.1
|
|
||||
Total assets
|
$
|
4,734.6
|
|
|
$
|
18,729.8
|
|
|
$
|
537.5
|
|
|
$
|
24,001.9
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Derivatives
|
$
|
—
|
|
|
$
|
(21.5
|
)
|
|
$
|
—
|
|
|
$
|
(21.5
|
)
|
Total liabilities
|
$
|
—
|
|
|
$
|
(21.5
|
)
|
|
$
|
—
|
|
|
$
|
(21.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
Securities
|
|
Residential
Mortgage-
backed
Securities
|
|
Other
Securities
|
|
Equity
Securities
|
|
Total
|
||||||||||
Three Months Ended March 31, 2018
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning balance at January 1, 2018
|
$
|
229.2
|
|
|
$
|
5.0
|
|
|
$
|
15.9
|
|
|
$
|
287.4
|
|
|
$
|
537.5
|
|
Total (losses) gains:
|
|
|
|
|
|
|
|
|
|
||||||||||
Recognized in net income
|
(0.3
|
)
|
|
—
|
|
|
—
|
|
|
(238.7
|
)
|
|
(239.0
|
)
|
|||||
Recognized in accumulated other comprehensive loss
|
0.5
|
|
|
—
|
|
|
(0.1
|
)
|
|
—
|
|
|
0.4
|
|
|||||
Purchases
|
19.9
|
|
|
0.1
|
|
|
—
|
|
|
255.6
|
|
|
275.6
|
|
|||||
Sales
|
(3.6
|
)
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
|
(4.5
|
)
|
|||||
Settlements
|
(6.0
|
)
|
|
(0.4
|
)
|
|
(0.7
|
)
|
|
—
|
|
|
(7.1
|
)
|
|||||
Transfers into Level III
|
20.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
20.8
|
|
|||||
Transfers out of Level III
|
—
|
|
|
—
|
|
|
(1.4
|
)
|
|
—
|
|
|
(1.4
|
)
|
|||||
Ending balance at March 31, 2018
|
$
|
260.5
|
|
|
$
|
4.7
|
|
|
$
|
13.7
|
|
|
$
|
303.4
|
|
|
$
|
582.3
|
|
Change in unrealized losses included in net income related to assets still held for the three months ended March 31, 2018
|
$
|
(0.5
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(0.5
|
)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Three Months Ended March 31, 2017
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning balance at January 1, 2017
|
$
|
238.8
|
|
|
$
|
12.0
|
|
|
$
|
42.8
|
|
|
$
|
187.8
|
|
|
$
|
481.4
|
|
Total (losses) gains:
|
|
|
|
|
|
|
|
|
|
||||||||||
Recognized in net income
|
(1.3
|
)
|
|
—
|
|
|
—
|
|
|
0.3
|
|
|
(1.0
|
)
|
|||||
Recognized in accumulated other comprehensive loss
|
3.6
|
|
|
—
|
|
|
0.1
|
|
|
(0.4
|
)
|
|
3.3
|
|
|||||
Purchases
|
34.8
|
|
|
1.5
|
|
|
9.5
|
|
|
36.0
|
|
|
81.8
|
|
|||||
Sales
|
(32.6
|
)
|
|
(1.5
|
)
|
|
—
|
|
|
(0.4
|
)
|
|
(34.5
|
)
|
|||||
Settlements
|
(19.6
|
)
|
|
(0.2
|
)
|
|
(0.4
|
)
|
|
—
|
|
|
(20.2
|
)
|
|||||
Transfers into Level III
|
8.3
|
|
|
—
|
|
|
1.2
|
|
|
—
|
|
|
9.5
|
|
|||||
Transfers out of Level III
|
(2.0
|
)
|
|
(4.6
|
)
|
|
(24.6
|
)
|
|
—
|
|
|
(31.2
|
)
|
|||||
Ending balance at March 31, 2017
|
$
|
230.0
|
|
|
$
|
7.2
|
|
|
$
|
28.6
|
|
|
$
|
223.3
|
|
|
$
|
489.1
|
|
Change in unrealized losses included in net income related to assets still held for the three months ended March 31, 2017
|
$
|
(1.7
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(1.7
|
)
|
|
Carrying
Value
|
|
Estimated Fair Value
|
||||||||||||||||
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
|||||||||||
March 31, 2018
|
|
|
|
|
|
|
|
|
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Other invested assets, long-term
|
$
|
3,460.8
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,460.8
|
|
|
$
|
3,460.8
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Debt:
|
|
|
|
|
|
|
|
|
|
||||||||||
Short-term borrowings
|
1,125.0
|
|
|
—
|
|
|
1,125.0
|
|
|
—
|
|
|
1,125.0
|
|
|||||
Commercial paper
|
695.7
|
|
|
—
|
|
|
695.7
|
|
|
—
|
|
|
695.7
|
|
|||||
Notes
|
17,811.5
|
|
|
—
|
|
|
18,118.1
|
|
|
—
|
|
|
18,118.1
|
|
|||||
Convertible debentures
|
253.7
|
|
|
—
|
|
|
1,202.5
|
|
|
—
|
|
|
1,202.5
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Other invested assets, long-term
|
$
|
3,343.8
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,343.8
|
|
|
$
|
3,343.8
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Debt:
|
|
|
|
|
|
|
|
|
|
||||||||||
Short-term borrowings
|
1,275.0
|
|
|
—
|
|
|
1,275.0
|
|
|
—
|
|
|
1,275.0
|
|
|||||
Commercial paper
|
803.6
|
|
|
—
|
|
|
803.6
|
|
|
—
|
|
|
803.6
|
|
|||||
Notes
|
17,592.7
|
|
|
—
|
|
|
18,815.1
|
|
|
—
|
|
|
18,815.1
|
|
|||||
Convertible debentures
|
260.5
|
|
|
—
|
|
|
1,215.7
|
|
|
—
|
|
|
1,215.7
|
|
7.
|
Income Taxes
|
8.
|
Retirement Benefits
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
Other Benefits
|
||||||||||||
|
Three Months Ended
March 31 |
|
Three Months Ended
March 31 |
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Service cost
|
$
|
2.1
|
|
|
$
|
2.5
|
|
|
$
|
0.3
|
|
|
$
|
0.3
|
|
Interest cost
|
13.6
|
|
|
16.6
|
|
|
3.8
|
|
|
5.2
|
|
||||
Expected return on assets
|
(36.8
|
)
|
|
(36.8
|
)
|
|
(6.1
|
)
|
|
(5.7
|
)
|
||||
Recognized actuarial loss
|
6.0
|
|
|
5.4
|
|
|
0.9
|
|
|
2.9
|
|
||||
Settlement loss
|
6.6
|
|
|
1.7
|
|
|
—
|
|
|
—
|
|
||||
Amortization of prior service credit
|
—
|
|
|
(0.1
|
)
|
|
(3.1
|
)
|
|
(3.4
|
)
|
||||
Net periodic benefit credit
|
$
|
(8.5
|
)
|
|
$
|
(10.7
|
)
|
|
$
|
(4.2
|
)
|
|
$
|
(0.7
|
)
|
|
Commercial
& Specialty
Business
|
|
Government
Business
|
|
Total
|
||||||
Gross medical claims payable, beginning of period
|
$
|
3,406.6
|
|
|
$
|
4,584.9
|
|
|
$
|
7,991.5
|
|
Ceded medical claims payable, beginning of period
|
(78.0
|
)
|
|
(26.9
|
)
|
|
(104.9
|
)
|
|||
Net medical claims payable, beginning of period
|
3,328.6
|
|
|
4,558.0
|
|
|
7,886.6
|
|
|||
Business combinations and purchase adjustments
|
—
|
|
|
199.2
|
|
|
199.2
|
|
|||
Net incurred medical claims:
|
|
|
|
|
|
||||||
Current period
|
5,825.2
|
|
|
11,445.9
|
|
|
17,271.1
|
|
|||
Prior periods redundancies
|
(337.0
|
)
|
|
(308.2
|
)
|
|
(645.2
|
)
|
|||
Total net incurred medical claims
|
5,488.2
|
|
|
11,137.7
|
|
|
16,625.9
|
|
|||
Net payments attributable to:
|
|
|
|
|
|
||||||
Current period medical claims
|
3,796.1
|
|
|
7,682.7
|
|
|
11,478.8
|
|
|||
Prior periods medical claims
|
2,221.7
|
|
|
3,405.4
|
|
|
5,627.1
|
|
|||
Total net payments
|
6,017.8
|
|
|
11,088.1
|
|
|
17,105.9
|
|
|||
Net medical claims payable, end of period
|
2,799.0
|
|
|
4,806.8
|
|
|
7,605.8
|
|
|||
Ceded medical claims payable, end of period
|
2.1
|
|
|
32.4
|
|
|
34.5
|
|
|||
Gross medical claims payable, end of period
|
$
|
2,801.1
|
|
|
$
|
4,839.2
|
|
|
$
|
7,640.3
|
|
|
Commercial
& Specialty
Business
|
|
Government
Business
|
|
Total
|
||||||
Gross medical claims payable, beginning of period
|
$
|
3,267.0
|
|
|
$
|
4,625.6
|
|
|
$
|
7,892.6
|
|
Ceded medical claims payable, beginning of period
|
(521.3
|
)
|
|
(17.8
|
)
|
|
(539.1
|
)
|
|||
Net medical claims payable, beginning of period
|
2,745.7
|
|
|
4,607.8
|
|
|
7,353.5
|
|
|||
Net incurred medical claims:
|
|
|
|
|
|
||||||
Current period
|
7,084.1
|
|
|
10,884.4
|
|
|
17,968.5
|
|
|||
Prior periods redundancies
|
(334.0
|
)
|
|
(460.6
|
)
|
|
(794.6
|
)
|
|||
Total net incurred medical claims
|
6,750.1
|
|
|
10,423.8
|
|
|
17,173.9
|
|
|||
Net payments attributable to:
|
|
|
|
|
|
||||||
Current period medical claims
|
4,560.2
|
|
|
7,212.0
|
|
|
11,772.2
|
|
|||
Prior periods medical claims
|
2,062.5
|
|
|
3,226.4
|
|
|
5,288.9
|
|
|||
Total net payments
|
6,622.7
|
|
|
10,438.4
|
|
|
17,061.1
|
|
|||
Net medical claims payable, end of period
|
2,873.1
|
|
|
4,593.2
|
|
|
7,466.3
|
|
|||
Ceded medical claims payable, end of period
|
439.6
|
|
|
14.7
|
|
|
454.3
|
|
|||
Gross medical claims payable, end of period
|
$
|
3,312.7
|
|
|
$
|
4,607.9
|
|
|
$
|
7,920.6
|
|
|
|
Three Months Ended
March 31 |
||||||
|
|
2018
|
|
2017
|
||||
Net incurred medical claims:
|
|
|
|
|
||||
Commercial & Specialty Business
|
|
$
|
5,488.2
|
|
|
$
|
6,750.1
|
|
Government Business
|
|
11,137.7
|
|
|
10,423.8
|
|
||
Total net incurred medical claims
|
|
16,625.9
|
|
|
17,173.9
|
|
||
Quality improvement and other claims expense
|
|
420.0
|
|
|
368.9
|
|
||
Benefit expense
|
|
$
|
17,045.9
|
|
|
$
|
17,542.8
|
|
10.
|
Debt
|
|
|
|
|
Outstanding principal amount
|
$
|
384.8
|
|
Unamortized debt discount
|
$
|
127.0
|
|
Net debt carrying amount
|
$
|
253.7
|
|
Equity component carrying amount
|
$
|
139.5
|
|
Conversion rate (shares of common stock per $1,000 of principal amount)
|
13.7742
|
|
|
Effective conversion price (per $1,000 of principal amount)
|
$
|
72.5990
|
|
11.
|
Commitments and Contingencies
|
12.
|
Capital Stock
|
Declaration Date
|
|
Record Date
|
|
Payment Date
|
|
Cash
Dividend
per Share
|
|
Total
|
Three Months Ended March 31, 2018
|
|
|
|
|
|
|
|
|
January 30, 2018
|
|
March 9, 2018
|
|
March 23, 2018
|
|
$0.75
|
|
$191.9
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2017
|
|
|
|
|
|
|
|
|
February 22, 2017
|
|
March 10, 2017
|
|
March 24, 2017
|
|
$0.65
|
|
$172.2
|
|
April 1, 2018
Through April 12, 2018 |
|
Three Months Ended March 31
|
||||||||
|
|
2018
|
|
2017
|
|||||||
Shares repurchased
|
0.4
|
|
|
1.7
|
|
|
0.3
|
|
|||
Average price per share
|
$
|
224.66
|
|
|
$
|
233.51
|
|
|
$
|
160.81
|
|
Aggregate cost
|
$
|
82.8
|
|
|
$
|
394.7
|
|
|
$
|
50.7
|
|
Authorization remaining at the end of the period
|
$
|
6,700.6
|
|
|
$
|
6,783.4
|
|
|
$
|
4,125.2
|
|
|
Number of
Shares
|
|
Weighted-
Average
Option Price
per Share
|
|
Weighted-
Average
Remaining
Contractual
Life (Years)
|
|
Aggregate
Intrinsic
Value
|
|||||
Outstanding at January 1, 2018
|
4.3
|
|
|
$
|
124.31
|
|
|
|
|
|
||
Granted
|
0.8
|
|
|
232.03
|
|
|
|
|
|
|||
Exercised
|
(0.5
|
)
|
|
99.33
|
|
|
|
|
|
|||
Forfeited or expired
|
—
|
|
|
172.73
|
|
|
|
|
|
|||
Outstanding at March 31, 2018
|
4.6
|
|
|
145.62
|
|
|
6.80
|
|
$
|
350.1
|
|
|
Exercisable at March 31, 2018
|
2.7
|
|
|
116.42
|
|
|
5.19
|
|
$
|
277.9
|
|
|
Restricted
Stock Shares
and Units
|
|
Weighted-
Average
Grant Date
Fair Value
per Share
|
|||
Nonvested at January 1, 2018
|
2.0
|
|
|
$
|
152.20
|
|
Granted
|
0.8
|
|
|
232.15
|
|
|
Vested
|
(0.9
|
)
|
|
147.29
|
|
|
Forfeited
|
—
|
|
|
176.68
|
|
|
Nonvested at March 31, 2018
|
1.9
|
|
|
180.43
|
|
|
Three Months Ended March 31
|
||||
|
2018
|
|
2017
|
||
Risk-free interest rate
|
2.90
|
%
|
|
2.31
|
%
|
Volatility factor
|
30.00
|
%
|
|
32.00
|
%
|
Quarterly dividend yield
|
0.323
|
%
|
|
0.397
|
%
|
Weighted-average expected life (years)
|
3.70
|
|
|
4.00
|
|
|
Three Months Ended March 31
|
||||||
|
2018
|
|
2017
|
||||
Options granted during the period
|
$
|
55.31
|
|
|
$
|
40.73
|
|
Restricted stock awards granted during the period
|
232.15
|
|
|
166.94
|
|
13.
|
Accumulated Other Comprehensive Loss
|
|
March 31
|
||||||
|
2018
|
|
2017
|
||||
Investments, excluding non-credit component of other-than-temporary impairments:
|
|
|
|
||||
Gross unrealized gains
|
$
|
239.1
|
|
|
$
|
811.0
|
|
Gross unrealized losses
|
(220.4
|
)
|
|
(124.3
|
)
|
||
Net pre-tax unrealized gains
|
18.7
|
|
|
686.7
|
|
||
Deferred tax liability
|
(4.7
|
)
|
|
(245.3
|
)
|
||
Net unrealized gains on investments
|
14.0
|
|
|
441.4
|
|
||
Non-credit components of other-than-temporary impairments on investments:
|
|
|
|
||||
Unrealized losses
|
—
|
|
|
(1.5
|
)
|
||
Deferred tax asset
|
—
|
|
|
0.5
|
|
||
Net unrealized non-credit component of other-than-temporary impairments on investments
|
—
|
|
|
(1.0
|
)
|
||
Cash flow hedges:
|
|
|
|
||||
Gross unrealized losses
|
(322.0
|
)
|
|
(239.4
|
)
|
||
Deferred tax asset
|
67.6
|
|
|
88.0
|
|
||
Net unrealized losses on cash flow hedges
|
(254.4
|
)
|
|
(151.4
|
)
|
||
Defined benefit pension plans:
|
|
|
|
||||
Deferred net actuarial loss
|
(612.1
|
)
|
|
(648.9
|
)
|
||
Deferred prior service credits
|
(1.0
|
)
|
|
(0.7
|
)
|
||
Deferred tax asset
|
158.8
|
|
|
254.8
|
|
||
Net unrecognized periodic benefit costs for defined benefit pension plans
|
(454.3
|
)
|
|
(394.8
|
)
|
||
Postretirement benefit plans:
|
|
|
|
||||
Deferred net actuarial loss
|
(76.6
|
)
|
|
(143.7
|
)
|
||
Deferred prior service costs
|
42.9
|
|
|
56.3
|
|
||
Deferred tax asset
|
8.7
|
|
|
34.1
|
|
||
Net unrecognized periodic benefit costs for postretirement benefit plans
|
(25.0
|
)
|
|
(53.3
|
)
|
||
Foreign currency translation adjustments:
|
|
|
|
||||
Gross unrealized losses
|
(1.4
|
)
|
|
(4.2
|
)
|
||
Deferred tax asset
|
0.5
|
|
|
1.5
|
|
||
Net unrealized losses on foreign currency translation adjustments
|
(0.9
|
)
|
|
(2.7
|
)
|
||
Accumulated other comprehensive loss
|
$
|
(720.6
|
)
|
|
$
|
(161.8
|
)
|
|
|
|
|
|
Three Months Ended March 31
|
||||||
|
2018
|
|
2017
|
||||
Investments:
|
|
|
|
||||
Net holding (loss) gain on investment securities arising during the period, net of tax benefit (expense) of 77.1 and ($46.3), respectively
|
$
|
(256.2
|
)
|
|
$
|
94.2
|
|
Reclassification adjustment for net realized loss (gain) on investment securities, net of tax (benefit) expense of ($3.1) and $7.5, respectively
|
11.5
|
|
|
(14.0
|
)
|
||
Total reclassification adjustment on investments
|
(244.7
|
)
|
|
80.2
|
|
||
Non-credit component of other-than-temporary impairments on investments:
|
|
|
|
||||
Non-credit component of other-than-temporary impairments on investments, net of tax expense of ($0.1) and ($2.1), respectively
|
0.2
|
|
|
3.6
|
|
||
Cash flow hedges:
|
|
|
|
||||
Holding gain, net of tax expense of ($7.8) and ($2.7), respectively
|
28.8
|
|
|
17.0
|
|
||
Other:
|
|
|
|
||||
Net change in unrecognized periodic benefit costs for defined benefit pension and postretirement benefit plans, net of tax expense of ($2.6) and ($2.3), respectively
|
7.7
|
|
|
3.9
|
|
||
Foreign currency translation adjustment, net of tax expense of ($0.2) and ($0.7), respectively
|
0.4
|
|
|
1.4
|
|
||
Net (loss) gain recognized in other comprehensive income, net of tax benefit (expense) of $63.3 and ($46.6), respectively
|
$
|
(207.6
|
)
|
|
$
|
106.1
|
|
14.
|
Earnings per Share
|
|
Three Months Ended
March 31 |
||||
|
2018
|
|
2017
|
||
Denominator for basic earnings per share – weighted-average shares
|
255.8
|
|
|
264.4
|
|
Effect of dilutive securities – employee stock options, nonvested restricted stock awards, convertible debentures and equity units
|
7.0
|
|
|
6.0
|
|
Denominator for diluted earnings per share
|
262.8
|
|
|
270.4
|
|
15.
|
Segment Information
|
|
Commercial
& Specialty
Business
|
|
Government
Business
|
|
Other
|
|
Total
|
||||||||
Three Months Ended March 31, 2018
|
|
|
|
|
|
|
|
||||||||
Operating revenue
|
$
|
9,066.4
|
|
|
$
|
13,262.4
|
|
|
$
|
13.5
|
|
|
$
|
22,342.3
|
|
Operating gain (loss)
|
1,408.4
|
|
|
490.9
|
|
|
(31.4
|
)
|
|
1,867.9
|
|
||||
Three Months Ended March 31, 2017
|
|
|
|
|
|
|
|
||||||||
Operating revenue
|
$
|
10,289.6
|
|
|
$
|
12,025.7
|
|
|
$
|
4.2
|
|
|
$
|
22,319.5
|
|
Operating gain (loss)
|
1,302.4
|
|
|
318.6
|
|
|
(35.6
|
)
|
|
1,585.4
|
|
|
Three Months Ended
March 31 |
||||||
|
2018
|
|
2017
|
||||
Commercial & Specialty Business
|
|
|
|
||||
Managed care products
|
$
|
7,363.9
|
|
|
$
|
8,649.0
|
|
Managed care services
|
1,282.2
|
|
|
1,222.6
|
|
||
Dental/Vision products and services
|
304.5
|
|
|
306.4
|
|
||
Other
|
115.8
|
|
|
111.6
|
|
||
Total Commercial & Specialty Business
|
9,066.4
|
|
|
10,289.6
|
|
||
Government Business
|
|
|
|
||||
Managed care products
|
13,152.2
|
|
|
11,918.2
|
|
||
Managed care services
|
110.2
|
|
|
107.5
|
|
||
Total Government Business
|
13,262.4
|
|
|
12,025.7
|
|
||
Other
|
|
|
|
||||
Other
|
13.5
|
|
|
4.2
|
|
||
Total product revenues
|
$
|
22,342.3
|
|
|
$
|
22,319.5
|
|
|
Three Months Ended
March 31 |
||||||
|
2018
|
|
2017
|
||||
Reportable segments’ operating revenues
|
$
|
22,342.3
|
|
|
$
|
22,319.5
|
|
Net investment income
|
229.2
|
|
|
207.2
|
|
||
Net realized (losses) gains on financial instruments
|
(26.1
|
)
|
|
7.3
|
|
||
Other-than-temporary impairment losses recognized in income
|
(7.9
|
)
|
|
(8.1
|
)
|
||
Total revenues
|
$
|
22,537.5
|
|
|
$
|
22,525.9
|
|
|
Three Months Ended
March 31 |
||||||
|
2018
|
|
2017
|
||||
Reportable segments’ operating gain
|
$
|
1,867.9
|
|
|
$
|
1,585.4
|
|
Net investment income
|
229.2
|
|
|
207.2
|
|
||
Net realized (losses) gains on financial instruments
|
(26.1
|
)
|
|
7.3
|
|
||
Other-than-temporary impairment losses recognized in income
|
(7.9
|
)
|
|
(8.1
|
)
|
||
Interest expense
|
(184.2
|
)
|
|
(235.0
|
)
|
||
Amortization of other intangible assets
|
(79.5
|
)
|
|
(41.8
|
)
|
||
Loss on extinguishment of debt
|
(19.1
|
)
|
|
—
|
|
||
Income before income tax expense
|
$
|
1,780.3
|
|
|
$
|
1,515.0
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
March 31
|
|
|
|
|
||||||
(In thousands)
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
||||
Medical Membership
|
|
|
|
|
|
|
|
||||
Customer Type
|
|
|
|
|
|
|
|
||||
Local Group
|
15,649
|
|
|
15,697
|
|
|
(48
|
)
|
|
(0.3
|
)%
|
Individual
|
755
|
|
|
1,886
|
|
|
(1,131
|
)
|
|
(60.0
|
)%
|
National:
|
|
|
|
|
|
|
|
||||
National Accounts
|
7,861
|
|
|
7,794
|
|
|
67
|
|
|
0.9
|
%
|
BlueCard
®
|
5,652
|
|
|
5,652
|
|
|
—
|
|
|
—
|
%
|
Total National
|
13,513
|
|
|
13,446
|
|
|
67
|
|
|
0.5
|
%
|
Medicare
|
1,713
|
|
|
1,476
|
|
|
237
|
|
|
16.1
|
%
|
Medicaid
|
6,436
|
|
|
6,556
|
|
|
(120
|
)
|
|
(1.8
|
)%
|
FEP
®
|
1,562
|
|
|
1,573
|
|
|
(11
|
)
|
|
(0.7
|
)%
|
Total Medical Membership by Customer Type
|
39,628
|
|
|
40,634
|
|
|
(1,006
|
)
|
|
(2.5
|
)%
|
Funding Arrangement
|
|
|
|
|
|
|
|
||||
Self-Funded
|
25,299
|
|
|
25,073
|
|
|
226
|
|
|
0.9
|
%
|
Fully-Insured
|
14,329
|
|
|
15,561
|
|
|
(1,232
|
)
|
|
(7.9
|
)%
|
Total Medical Membership by Funding Arrangement
|
39,628
|
|
|
40,634
|
|
|
(1,006
|
)
|
|
(2.5
|
)%
|
Reportable Segment
|
|
|
|
|
|
|
|
||||
Commercial & Specialty Business
|
29,917
|
|
|
31,029
|
|
|
(1,112
|
)
|
|
(3.6
|
)%
|
Government Business
|
9,711
|
|
|
9,605
|
|
|
106
|
|
|
1.1
|
%
|
Total Medical Membership by Reportable Segment
|
39,628
|
|
|
40,634
|
|
|
(1,006
|
)
|
|
(2.5
|
)%
|
Other Membership & Customers
|
|
|
|
|
|
|
|
||||
Life and Disability Members
|
4,641
|
|
|
4,715
|
|
|
(74
|
)
|
|
(1.6
|
)%
|
Dental Members
|
5,786
|
|
|
5,859
|
|
|
(73
|
)
|
|
(1.2
|
)%
|
Dental Administration Members
|
5,357
|
|
|
5,395
|
|
|
(38
|
)
|
|
(0.7
|
)%
|
Vision Members
|
6,781
|
|
|
6,793
|
|
|
(12
|
)
|
|
(0.2
|
)%
|
Medicare Advantage Part D Members
|
912
|
|
|
668
|
|
|
244
|
|
|
36.5
|
%
|
Medicare Part D Standalone Members
|
316
|
|
|
324
|
|
|
(8
|
)
|
|
(2.5
|
)%
|
|
|
Three Months Ended
March 31 |
|
|
|||||||||||
|
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Total operating revenue
|
$
|
22,342.3
|
|
|
$
|
22,319.5
|
|
|
$
|
22.8
|
|
|
0.1
|
%
|
|
Net investment income
|
229.2
|
|
|
207.2
|
|
|
22.0
|
|
|
10.6
|
%
|
||||
Net realized (losses) gains on financial instruments
|
(26.1
|
)
|
|
7.3
|
|
|
(33.4
|
)
|
|
457.5
|
%
|
||||
Other-than-temporary impairment losses on investments
|
(7.9
|
)
|
|
(8.1
|
)
|
|
0.2
|
|
|
(2.5
|
)%
|
||||
Total revenues
|
22,537.5
|
|
|
22,525.9
|
|
|
11.6
|
|
|
0.1
|
%
|
||||
Benefit expense
|
17,045.9
|
|
|
17,542.8
|
|
|
(496.9
|
)
|
|
(2.8
|
)%
|
||||
Selling, general and administrative expense
|
3,428.5
|
|
|
3,191.3
|
|
|
237.2
|
|
|
7.4
|
%
|
||||
Other expense
1
|
282.8
|
|
|
276.8
|
|
|
6.0
|
|
|
2.2
|
%
|
||||
Total expenses
|
20,757.2
|
|
|
21,010.9
|
|
|
(253.7
|
)
|
|
(1.2
|
)%
|
||||
Income before income tax expense
|
1,780.3
|
|
|
1,515.0
|
|
|
265.3
|
|
|
17.5
|
%
|
||||
Income tax expense
|
467.8
|
|
|
505.1
|
|
|
(37.3
|
)
|
|
(7.4
|
)%
|
||||
Net income
|
$
|
1,312.5
|
|
|
$
|
1,009.9
|
|
|
$
|
302.6
|
|
|
30.0
|
%
|
|
|
|
|
|
|
|
|
|
||||||||
Average diluted shares outstanding
|
262.8
|
|
|
270.4
|
|
|
(7.6
|
)
|
|
(2.8
|
)%
|
||||
Diluted net income per share
|
$
|
4.99
|
|
|
$
|
3.73
|
|
|
$
|
1.26
|
|
|
33.8
|
%
|
|
Benefit expense ratio
2
|
81.5
|
%
|
|
83.7
|
%
|
|
|
|
(220)bp
3
|
|
|||||
Selling, general and administrative expense ratio
4
|
15.3
|
%
|
|
14.3
|
%
|
|
|
|
100bp
3
|
|
|||||
Income before income tax expense as a percentage of total revenues
|
7.9
|
%
|
|
6.7
|
%
|
|
|
|
120bp
3
|
|
|||||
Net income as a percentage of total revenues
|
5.8
|
%
|
|
4.5
|
%
|
|
|
|
130bp
3
|
|
|||||
|
|
|
|
|
|
|
|
|
1
|
Includes interest expense, amortization of other intangible assets and loss on extinguishment of debt.
|
2
|
Benefit expense ratio represents benefit expense as a percentage of premium revenue. Premiums for the
three months ended March 31, 2018
and
2017
were
$20,902.8
and
$20,951.3
, respectively. Premiums are included in total operating revenue presented above.
|
3
|
bp = basis point; one hundred basis points = 1%.
|
4
|
Selling, general and administrative expense ratio represents selling, general and administrative expense as a percentage of total operating revenue.
|
|
|
Three Months Ended
March 31 |
|
|
|||||||||||
|
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Commercial & Specialty Business
|
|
|
|
|
|
|
|
||||||||
Operating revenue
|
$
|
9,066.4
|
|
|
$
|
10,289.6
|
|
|
$
|
(1,223.2
|
)
|
|
(11.9
|
)%
|
|
Operating gain
|
$
|
1,408.4
|
|
|
$
|
1,302.4
|
|
|
$
|
106.0
|
|
|
8.1
|
%
|
|
Operating margin
|
15.5
|
%
|
|
12.7
|
%
|
|
|
|
|
280
|
bp
|
||||
|
|
|
|
|
|
|
|
||||||||
Government Business
|
|
|
|
|
|
|
|
||||||||
Operating revenue
|
$
|
13,262.4
|
|
|
$
|
12,025.7
|
|
|
$
|
1,236.7
|
|
|
10.3
|
%
|
|
Operating gain
|
$
|
490.9
|
|
|
$
|
318.6
|
|
|
$
|
172.3
|
|
|
54.1
|
%
|
|
Operating margin
|
3.7
|
%
|
|
2.6
|
%
|
|
|
|
|
110
|
bp
|
||||
|
|
|
|
|
|
|
|
||||||||
Other
|
|
|
|
|
|
|
|
||||||||
Operating revenue
1
|
$
|
13.5
|
|
|
$
|
4.2
|
|
|
$
|
9.3
|
|
|
221.4
|
%
|
|
Operating loss
2
|
$
|
(31.4
|
)
|
|
$
|
(35.6
|
)
|
|
$
|
4.2
|
|
|
(11.8
|
)%
|
|
|
|
|
|
|
|
|
|
|
1
|
Fluctuations not material.
|
2
|
Fluctuations are primarily a result of changes in unallocated corporate expenses.
|
|
|
|
|
|
|
|
Favorable Developments by
Changes in Key Assumptions |
||||||
|
|
|
|
|
|
|
Three Months Ended
March 31 |
||||||
|
|
|
|
|
|
|
2018
|
|
2017
|
||||
Assumed trend factors
|
|
|
|
|
|
|
$
|
412.7
|
|
|
$
|
485.3
|
|
Assumed completion factors
|
|
|
|
|
|
|
232.5
|
|
|
309.3
|
|
||
Total
|
|
|
|
|
|
|
$
|
645.2
|
|
|
$
|
794.6
|
|
|
Three Months Ended
March 31 |
||||||
|
2018
|
|
2017
|
||||
Cash flows provided by (used in):
|
|
|
|
||||
Operating activities
|
$
|
2,214.9
|
|
|
$
|
2,688.2
|
|
Investing activities
|
(565.9
|
)
|
|
(1,227.0
|
)
|
||
Financing activities
|
(627.7
|
)
|
|
1,234.3
|
|
||
Effect of foreign exchange rates on cash and cash equivalents
|
0.4
|
|
|
1.6
|
|
||
Change in cash and cash equivalents
|
$
|
1,021.7
|
|
|
$
|
2,697.1
|
|
ITEM 3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
ITEM 1A.
|
RISK FACTORS
|
ITEM 2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
Period
|
Total Number
of Shares
Purchased
1
|
|
Average
Price Paid
per Share
|
|
Total Number
of Shares
Purchased
as Part
of Publicly
Announced
Programs
2
|
|
Approximate
Dollar Value
of Shares
that May Yet
Be Purchased
Under the
Programs
|
||||||
(in millions, except share and per share data)
|
|
|
|
|
|
|
|
||||||
January 1, 2018 to January 31, 2018
|
435,250
|
|
|
$
|
236.44
|
|
|
434,377
|
|
|
$
|
7,075.4
|
|
February 1, 2018 to February 28, 2018
|
582,804
|
|
|
235.47
|
|
|
582,569
|
|
|
6,938.2
|
|
||
March 1, 2018 to March 31, 2018
|
987,031
|
|
|
230.82
|
|
|
673,393
|
|
|
6,783.4
|
|
||
|
2,005,085
|
|
|
|
|
1,690,339
|
|
|
|
1
|
Total number of shares purchased includes 314,746 shares delivered to or withheld by us in connection with employee payroll tax withholding upon exercise or vesting of stock awards. Stock grants to employees and directors and stock issued for stock option plans and stock purchase plans in the consolidated statements of shareholders’ equity are shown net of these shares purchased.
|
2
|
Represents the number of shares repurchased through the common stock repurchase program authorized by our Board of Directors, which the Board of Directors evaluates periodically. During the three months ended
March 31, 2018
, we repurchased
1,690,339
shares at a cost of $394.7 under the program, including the cost of options to purchase shares. The Board of Directors has authorized our common stock repurchase program since 2003. The Board of Director's most recent authorized increase to the program was
$5,000.0
on December 7, 2017. Between April 1, 2018 and April 12, 2018, we repurchased 368,800 shares at a cost of
$82.8
, bringing our current availability to
$6,700.6
at April 12, 2018. No duration has been placed on our common stock repurchase program, and we reserve the right to discontinue the program at any time.
|
ITEM 3.
|
DEFAULTS UPON SENIOR SECURITIES
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
ITEM 5.
|
OTHER INFORMATION
|
ITEM 6.
|
EXHIBITS
|
|
|
|
|
|
ANTHEM, INC.
Registrant
|
||
|
|
|
|
|
|
|
|
|
|
|
|
Date: April 25, 2018
|
By:
|
|
/
S
/ J
OHN
E. G
ALLINA
|
|
|
|
John E. Gallina
Executive Vice President and Chief Financial Officer
(Duly Authorized Officer and Principal Financial Officer)
|
|
|
|
|
|
|
|
|
Date: April 25, 2018
|
By:
|
|
/
S
/ R
ONALD
W. P
ENCZEK
|
|
|
|
Ronald W. Penczek
Senior Vice President and Chief Accounting Officer
(Principal Accounting Officer)
|
Notice:
|
You have been granted the following nonqualified stock option to purchase shares of common stock of the Company in accordance with the terms of the Plan and the attached Nonqualified Stock Option Award Agreement.
|
Exercisability:
|
Subject to the terms of the Plan and this Agreement, your Option will become exercisable on and after the dates indicated below as to the number of Shares set forth below opposite each such date, plus any Shares as to which your Option could have been exercised previously but was not so exercised.
|
Shares
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration Date:
|
Your Option will expire ten years from the Grant Date, subject to earlier termination as set forth in the Plan and this Agreement.
|
Acceptance:
|
In order to accept your Options, you must electronically accept this Agreement through the Company’s broker at any time within ninety (90) days after the Grant Date. To effect your acceptance, please follow the instructions included with your grant materials. Acceptance of the Agreement includes acceptance of the terms and conditions of the Plan. If you do not timely and electronically accept this Agreement, this Agreement will be null and void as of the 90th day after the Grant Date and you will have no right or claim to the Options described above.
|
2.
|
Method of Exercise of the Option
.
|
9.
|
Compliance with Laws and Regulations
.
|
Notice:
|
You have been granted the following award of restricted stock units of common stock of the Company in accordance with the terms of the Plan and the attached Restricted Stock Unit Award Agreement.
|
Period of Restriction:
|
The Period of Restriction applicable to the number of your Restricted Stock Units listed in the “Shares” column below, and any related Dividend Equivalents, shall commence on the Grant Date and shall lapse on the date listed in the “Lapse Date” column below.
|
Shares
|
Lapse Date
|
|
|
|
|
|
|
Acceptance:
|
In order to accept your Restricted Stock Units, you must electronically accept this Agreement through the Company’s broker at any time within ninety (90) days after the Grant Date. To effect your acceptance, please follow the instructions included with your grant materials. Acceptance of the Agreement includes acceptance of the terms and conditions of the Plan. If you do not timely and electronically accept this Agreement, this Agreement will be null and void as of the 90th day after the Grant Date and you will have no right or claim to the Restricted Stock Units described above.
|
3.
|
Termination
.
|
10.
|
Compliance with Laws and Regulations
.
|
Adjusted Net Income Scale
|
For the Cumulative Net Income performance measure, you will earn between 0% and [•]% (share amounts will be interpolated) of three-fourths of the number of Performance Stock Units originally covered by the Grant. The total number of Performance Stock Units, as adjusted for achievement of the Adjusted Net Income performance measure, will vest on the date listed in the Vesting Date column above. If achievement of any performance measure results in a number of shares awarded that is more or less than 75%, then the number of Dividend Equivalents payable upon the Vesting Date shall be adjusted accordingly.
|
|||
|
|
Threshold
|
Target
|
Maximum
|
|
Cumulative Adjusted Net Income (2018-2020)
|
|
|
|
|
Percent of Shares Vesting
|
|
|
|
|
|
|
|
|
|
In the event that a Change of Control (as defined in the Plan) occurs before the end of the Performance Period, the Compensation Committee of the Board of Directors of Anthem, Inc. will determine the extent to which the performance measures described above have been achieved as of the date of the Change of Control, and the number of Performance Stock Units earned will be based on such level of achievement. If the successor company does not assume the Performance Stock Unit Grant, the number of earned Performance Stock Units as so determined shall immediately vest upon the Change of Control and the Shares covered by the award shall be immediately delivered upon the Change of Control, provided that in the event that the Performance Stock Units are deferred compensation within the meaning of Code Section 409A, such Stock Units shall only be delivered upon the Change of Control if such Change of Control is a “change in control event” within the meaning of Code Section 409A and the delivery is made in accordance with Treasury Regulation 1.409A-3(j)(ix).
If the successor does assume the Performance Stock Unit Grant and your employment continues with the successor, the number of earned Performance Stock Units as so determined will be paid on the Vesting Date, provided that you continue to be employed through the Vesting Date (subject to earlier payment on a termination without Cause, Good Reason (or due to Retirement), or by reason of death or Disability as provided in the Award Agreement).
|
|||
Acceptance:
|
In order to accept your Performance Stock Units, you must electronically accept this Agreement through the Company’s broker at any time within ninety (90) days after the Grant Date. To effect your acceptance, please follow the instructions included with your grant materials. Acceptance of the Agreement includes acceptance of the terms and conditions of the Plan. If you do not timely and electronically accept this Agreement, this Agreement will be null and void as of the 90th day after the Grant Date and you will have no right or claim to the Performance Stock Units described above.
|
Date of Retirement
|
Maximum Percentage of Performance Stock Units
(% multiplied by the number of Performance Stock Units originally covered by the Grant) |
Prior to July 1, 2019
|
|
July 1, 2019 through December 31, 2019
|
|
January 1, 2020 through June 30, 2020
|
|
July 1, 2020 through December 31, 2020
|
|
January 1, 2021 through March 1, 2021
|
|
Participant:
|
[●]
|
|||
Company:
|
Anthem, Inc.
|
|||
Notice:
|
You have been granted the following award of performance stock units of common stock of the Company in accordance with the terms of the Plan and the attached Performance Stock Unit Agreement.
|
|||
Plan:
|
2017 Anthem Incentive Compensation Plan
|
|||
Grant:
|
Grant Date: [●]
Number of Performance Stock Units: [●]
|
|||
Performance Period:
|
The period beginning on the Grant Date and ending on the Vesting Date is the Performance Period. Subject to achievement of the performance measures described below, the number of your Performance Stock Units listed in the “Shares” column, and any related Dividend Equivalents shall vest on the date listed in the “Vesting Date” column. Achievement of the performance measures described below may increase or decrease the total number of Performance Stock Units covered by the Grant and any related Dividend Equivalents that vest on the Vesting Date.
|
|||
|
Shares
|
Vesting Date
|
||
|
|
|||
|
|
|
|
|
|
Achievement of the following performance measures must be approved by the Compensation Committee of the Board of Directors of Anthem, Inc. You will earn between 0% and [•]% (share amounts will be interpolated) of the number of Performance Stock Units originally covered by the Grant. The total number of Performance Stock Units, as adjusted for achievement of the performance measures, will vest on the date listed in the Vesting Date column above. If achievement of the performance measure results in a number of shares awarded that is more or less than 100%, then the number of Dividend Equivalents payable upon the Vesting Date shall be adjusted accordingly.
|
|||
|
Annual Run Rate Value (Annual Gross Financial Improvement (Savings))
|
|
|
|
|
Percent of Shares Vesting
|
|
|
|
|
|
|
|
|
|
In the event that a Change of Control (as defined in the Plan) occurs before your Termination, your Performance Stock Unit Grant will remain subject to the terms of this Agreement, unless the successor company does not assume the Performance Stock Unit Grant. If the successor company does not assume the Performance Stock Unit Grant, then the Performance Stock Units shall immediately vest upon a Change of Control and the Shares covered by the award shall be immediately delivered upon the Change of Control, provided that in the event that the Performance Stock Units are deferred compensation within the meaning of Code Section 409A, such Stock Units shall only be delivered upon the Change of Control if such Change of Control is a “change in control event” within the meaning of Code Section 409A and the delivery is made in accordance with Treasury Regulation 1-409A-3(j)(ix).
|
Acceptance:
|
In order to accept your Performance Stock Units, you must electronically accept this Agreement through the Company’s broker at any time within ninety (90) days after the Grant Date. To effect your acceptance, please follow the instructions included with your grant materials. Acceptance of the Agreement includes acceptance of the terms and conditions of the Plan. If you do not timely and electronically accept this Agreement, this Agreement will be null and void as of the 90th day after the Grant Date and you will have no right or claim to the Performance Stock Units described above.
|
1.
|
I have reviewed this report on Form 10-Q of Anthem, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
Date: April 25, 2018
|
|
/s/ GAIL K. BOUDREAUX
|
|
|
President and Chief Executive Officer
|
1.
|
I have reviewed this report on Form 10-Q of Anthem, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: April 25, 2018
|
|
/s/ JOHN E. GALLINA
|
|
|
Executive Vice President and
Chief Financial Officer
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ GAIL K. BOUDREAUX
|
|
Gail K. Boudreaux
|
|
President and Chief Executive Officer
|
|
April 25, 2018
|
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ JOHN E. GALLINA
|
|
John E. Gallina
|
|
Executive Vice President and Chief Financial Officer
|
|
April 25, 2018
|
|